×
About 1,352 results

ALLMedicine™ Hypereosinophilic Syndrome Center

Research & Reviews  663 results

Idiopathic hypereosinophilic syndrome in hemodialysis patients: Case reports.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969317
Medicine Mutsuyoshi Y, Hirai K et. al.

Mar 17th, 2021 - Herein, we report 3 hemodialysis patients with idiopathic hypereosinophilic syndrome who were successfully treated using corticosteroid therapy. Case 1 was a 63-year-old man who was undergoing hemodialysis because of bilateral nephrectomy and deve...

New Treatment for Hypereosinophilic Syndrome.
https://doi.org/10.1097/01.NAJ.0000737288.71779.77
The American Journal of Nursing; Aschenbrenner DS

Feb 24th, 2021 - Mepolizumab (Nucala) has been approved to treat hypereosinophilic syndrome.Nurses should read the package insert for directions on how to reconstitute and administer the drug subcutaneously. Patient education will be needed regarding use of the au...

Hypereosinophilic syndrome with multiorgan involvement: an interdisciplinary work-up.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868273
BMJ Case Reports; Looman KIM, Nuver ME et. al.

Feb 5th, 2021 - A previously healthy 40-year-old man was referred to our emergency department with pruritic skin lesions and dyspnoea. Laboratory investigation revealed hypereosinophilia. Further diagnostic work-up confirmed the diagnosis of idiopathic hypereosin...

Missed hypereosinophilic syndrome in a critically ill patient with systemic lupus eryth...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845666
BMJ Case Reports; Ling Y, Bell MJ et. al.

Jan 29th, 2021 - A high functioning 74-year-old man with systemic lupus erythematosus presented to the emergency department with acute anxiety. He was found to have elevated cardiac enzymes and admitted to the cardiology service for investigation. In hospital, he ...

Irreversible coronary aneurysm presenting as acute coronary syndrome in a child with hy...
https://doi.org/10.1017/S1047951120004862
Cardiology in the Young; Tahouri T, Mahdavi M et. al.

Jan 25th, 2021 - Hypereosinophilic syndrome is defined as persistent eosinophilia in the blood for more than 6 months, without any identifiable cause and with end-organ involvement evidence. Cardiac manifestations of HES include heart failure due to restrictive ca...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  679 results

Idiopathic hypereosinophilic syndrome in hemodialysis patients: Case reports.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969317
Medicine Mutsuyoshi Y, Hirai K et. al.

Mar 17th, 2021 - Herein, we report 3 hemodialysis patients with idiopathic hypereosinophilic syndrome who were successfully treated using corticosteroid therapy. Case 1 was a 63-year-old man who was undergoing hemodialysis because of bilateral nephrectomy and deve...

New Treatment for Hypereosinophilic Syndrome.
https://doi.org/10.1097/01.NAJ.0000737288.71779.77
The American Journal of Nursing; Aschenbrenner DS

Feb 24th, 2021 - Mepolizumab (Nucala) has been approved to treat hypereosinophilic syndrome.Nurses should read the package insert for directions on how to reconstitute and administer the drug subcutaneously. Patient education will be needed regarding use of the au...

Hypereosinophilic syndrome with multiorgan involvement: an interdisciplinary work-up.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868273
BMJ Case Reports; Looman KIM, Nuver ME et. al.

Feb 5th, 2021 - A previously healthy 40-year-old man was referred to our emergency department with pruritic skin lesions and dyspnoea. Laboratory investigation revealed hypereosinophilia. Further diagnostic work-up confirmed the diagnosis of idiopathic hypereosin...

Missed hypereosinophilic syndrome in a critically ill patient with systemic lupus eryth...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845666
BMJ Case Reports; Ling Y, Bell MJ et. al.

Jan 29th, 2021 - A high functioning 74-year-old man with systemic lupus erythematosus presented to the emergency department with acute anxiety. He was found to have elevated cardiac enzymes and admitted to the cardiology service for investigation. In hospital, he ...

Irreversible coronary aneurysm presenting as acute coronary syndrome in a child with hy...
https://doi.org/10.1017/S1047951120004862
Cardiology in the Young; Tahouri T, Mahdavi M et. al.

Jan 25th, 2021 - Hypereosinophilic syndrome is defined as persistent eosinophilia in the blood for more than 6 months, without any identifiable cause and with end-organ involvement evidence. Cardiac manifestations of HES include heart failure due to restrictive ca...

see more →

News  5 results

FDA OKs Mepolizumab (Nucala) for Hypereosinophilic Syndrome
https://www.staging.medscape.com/viewarticle/938221

Sep 27th, 2020 - The US Food and Drug Administration (FDA) has expanded the indication for mepolizumab (Nucala, GlaxoSmithKline) to include patients with hypereosinophilic syndrome (HES). Mepolizumab is indicated for adults and children aged 12 years and older wit...

FDA OKs Mepolizumab (Nucala) for Hypereosinophilic Syndrome
https://www.medscape.com/viewarticle/938221

Sep 27th, 2020 - The US Food and Drug Administration (FDA) has expanded the indication for mepolizumab (Nucala, GlaxoSmithKline) to include patients with hypereosinophilic syndrome (HES). Mepolizumab is indicated for adults and children aged 12 years and older wit...

CHMP recommends approval of generic imatinib
https://www.mdedge.com/hematology-oncology/article/185423/cythemias/chmp-recommends-approval-generic-imatinib
HT Staff

Sep 18th, 2017 - Photo by Patrick Pelletier Imatinib tablet cut with a pill splitter The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended granting marketing authorization for Imatinib Teva B. V.

Imatinib Mesylate–Induced Lichenoid Drug Eruption
https://www.mdedge.com/dermatology/article/132728/nonmelanoma-skin-cancer/imatinib-mesylate-induced-lichenoid-drug-eruption/page/0/1

Mar 6th, 2017 - Comment In addition to CML, imatinib has been approved for acute lymphoblastic leukemia, myelodysplastic syndromes, aggressive systemic mastocytosis, hypereosinophilic syndrome, chronic eosinophilic leukemia, dermatofibrosarcoma protuberans, and G.

AACR: Gleevec Effective in Rare Myeloproliferative Disorder
https://www.medpagetoday.com/hematologyoncology/hematology/2977

Apr 2nd, 2006 - Action Points Be aware that this study found Gleevec effective and safe in patients with idiopathic hypereosinophilic syndrome (HES) who have a translocation between the FIP1L1 and PDGFR genes. This is an off-label use of Gleevec. This study was p...

see more →

Patient Education  3 results see all →